Mavorixafor API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Mavorixafor API is a high-quality pharmaceutical active ingredient classified as a C-X-C chemokine receptor type 4 (CXCR4) antagonist and immunomodulatory pharmaceutical agent. Mavorixafor is a synthetic small-molecule compound associated with pharmaceutical applications involving CXCR4 receptor inhibition and rare immune system disorders.

Mavorixafor works by blocking the interaction of CXCR4 with its ligand CXCL12. CXCR4 signaling plays an important role in the movement and retention of white blood cells within the bone marrow. Inhibition of this pathway supports the mobilization of mature neutrophils and lymphocytes into peripheral circulation.

Mavorixafor is associated with pharmaceutical applications related to WHIM syndrome, a rare immune disorder characterized by warts, hypogammaglobulinemia, infections, and myelokathexis. It is also used in CXCR4 antagonist research, immunology research, and pharmaceutical development programs.

Swapnroop Drugs and Pharmaceuticals is a trusted Mavorixafor API manufacturer and bulk supplier in Maharashtra, India, offering reliable pharmaceutical raw material supply solutions for domestic and international markets. We support pharmaceutical companies, formulation manufacturers, research organizations, and global buyers with quality-focused sourcing, technical documentation, and dependable supply services.

Our Mavorixafor API is supplied with applicable product specifications and quality documentation based on customer and manufacturing requirements. We focus on consistent quality, reliable supply, professional service, suitable pharmaceutical packaging, and international pharmaceutical business support.

As a reliable Mavorixafor API supplier in India, Swapnroop Drugs and Pharmaceuticals supports bulk requirements, pharmaceutical formulation development, immunology research, analytical applications, and export enquiries. Contact us for Mavorixafor API price, bulk quantity requirements, specifications, COA, documentation, packaging details, and international supply requirements.

Applications

  • Used in CXCR4 receptor antagonist pharmaceutical development
  • Used in immunology and immune disorder research
  • Associated with WHIM syndrome pharmaceutical applications
  • Applied in neutrophil and lymphocyte mobilization research
  • Used in pharmaceutical formulation and analytical development
  • Used in CXCR4-CXCL12 signaling pathway research
  • Suitable for pharmaceutical and biomedical research applications

Packaging

Mavorixafor API is supplied in suitable pharmaceutical-grade packaging systems to maintain product quality and stability. Standard packaging may include double LDPE bags placed inside HDPE containers or drums. Customized bulk and export packaging options are available according to customer requirements.

Storage

Store in a tightly closed container under recommended controlled storage conditions. Protect from moisture, excessive heat, and direct light. Maintain storage conditions according to manufacturer specifications and product stability requirements.

Get Bulk Quote via WhatsApp